Abstract
The present investigation involves the preparation of gelatin nanoparticles laden with naproxen, an anti-inflammatory drug. The nanoparticulate formulations were prepared by a modified two step desolvation technique upon varying the crosslinking ratio with drug and polymer and were assessed for their analgesic and anti-inflammatory activities. Particles of nanometer size range were formulated (177 ± 2.17–142 ± 2.06 nm) and the size distribution was monodisperse in the entire prepared batches with low polydispersity index. Entrapment efficiency of the nanoformulations was from 65 to 42%. DSC thermograms reported molecular level dispersion of drug in the nanoparticles whilst FTIR studies exhibited no drug-polymer interaction. Batches (NGP1-NGP8) exhibited an initial burst release followed by controlled release of the drug, the Korsmeyer-Peppas showed better linearity and the formulations displayed non-Fickian drug release pattern. Investigations were executed to analyze the analgesic and anti-inflammatory effects of the optimized formulation. The drug loaded nanoparticles exhibited significant (P<0.05) analgesic activity (acetic acid induced abdominal constriction & tail flick test in mice) and anti-inflammatory activity (carrageenan induced rat paw edema) in comparison to marketed product.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
